Company Analysis

Dare Bioscience, Inc. (DARE)

Nasdaq: DARE · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2007
Grade4.7
◀ Past 3.4● Present 3.4▶ Future 6.7
1 est.

Who runs Dare Bioscience, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
2
of 7 people with a filing in the last fifteen months
Directors reporting now
5
25 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Johnson Sabrina MartucciChef Executive OfficerJul 2017Feb 20, 2026none
Haring-Layton MardeeChief Accounting OfficerJan 2024Feb 2, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Grossman Jessica D.directorApr 2018Jul 2, 2026none
Kelley Susan L.directorOct 2014Jul 2, 2026none
Matz Gregory WdirectorSep 2018Jul 2, 2026none
Rastetter William HdirectorApr 2014Jul 2, 2026none
Steele Robin JoandirectorJul 2017Jul 2, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton DARE · research, not advice